Table 1: Cervical Cancer Screening (PAP smear testing) Rate
(Percentage) Among Female Patients at the Rambam Gynecology Outpatient Clinic.
|
Year |
2004 |
2005 |
2006 |
2007 |
2008 |
2009 |
2010 |
Total |
|
|
N |
338 |
283 |
149 |
349 |
261 |
232 |
166 |
1778 |
|
|
% |
19.0 |
15.9 |
8.38 |
19.6 |
14.7 |
13.1 |
9.34 |
100 |
|
|
Age groups |
|||||||||
|
<21 |
22.2 |
20.1 |
4.03 |
21.5 |
19.9 |
7.33 |
1.81 |
16.1 |
|
|
21-25 |
9.76 |
10.6 |
6.71 |
10.0 |
9.58 |
6.89 |
5.42 |
8.89 |
|
|
26-30 |
11.0 |
7.07 |
12.1 |
11.8 |
11.1 |
15.5 |
15.7 |
11.6 |
|
|
31-35 |
11.8 |
8.8 |
10.1 |
9.45 |
10.7 |
13.8 |
8.43 |
10.5 |
|
|
36-40 |
12.4 |
17.3 |
19.5 |
11.2 |
15.3 |
12.1 |
10.2 |
13.7 |
|
|
41-50 |
17.2 |
17.3 |
31.5 |
21.5 |
18.8 |
25.0 |
34.3 |
22.1 |
|
|
51-64 |
14.5 |
15.5 |
16.1 |
14.3 |
13.8 |
17.2 |
23.5 |
15.9 |
|
|
> 65 |
1.18 |
1.77 |
0.00 |
0.86 |
0.77 |
2.16 |
0.60 |
1.12 |
|
|
Indications |
|||||||||
|
Routine |
71.3 |
66.1 |
65.8 |
67.3 |
69.0 |
65.1 |
68.1 |
67.9 |
|
|
Follow-up |
10.0 |
6.00 |
10.1 |
8.31 |
10.7 |
12.9 |
13.3 |
9.84 |
|
|
Post-coital Bleeding |
3.25 |
3.18 |
3.35 |
3.43 |
4.21 |
04.3 |
4.22 |
3.66 |
|
|
Autoimmune disease |
0.59 |
1.06 |
4.03 |
1.14 |
1.15 |
2.15 |
0.00 |
1.29 |
|
|
S/P chemotherapy |
5.91 |
4.59 |
4.70 |
6.30 |
5.36 |
4.74 |
7.23 |
5.57 |
|
|
Metrorrhagia |
0.29 |
1.06 |
0.00 |
2.87 |
1.92 |
1.29 |
1.20 |
1.35 |
|
|
Gynecological infection |
0.30 |
3.53 |
4.03 |
1.43 |
1.92 |
2.59 |
1.20 |
1.97 |
|
|
Combination |
0.59 |
2.47 |
1.34 |
1.72 |
2.68 |
3.45 |
1.20 |
1.97 |
|
|
History of Ectropion |
7.69 |
10.6 |
6.71 |
7.45 |
3.06 |
3.45 |
3.61 |
6.41 |
|